In vitro characterization of physico-chemical properties, cytotoxicity, bioactivity of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate nasal powder formulation.
Olfactory dysfunction in acute rhinosinusitis: intranasal sodium hyaluronate as adjuvant treatment.
Cytofunctional changes in nasal ciliated cells in patients treated with hyaluronate after nasal surgery.
Combination of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate for the treatment of inflammatory lung diseases: An in vitro study.
Antiadhesive and antibiofilm activity of hyaluronic acid against bacteria responsible for respiratory tract infections.
Ancillary therapy of intranasal T-LysYal® for patients with allergic, non-allergic, and mixed rhinitis.
Treatment of allergic and vasomotor rhinitis the role of beclomethasone dipropionate and hyaluronic acid (with high molecular weight)